For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Medimmune Oncology, Inc.

USPTO Granted Patents = 16

CIPO Patents = 5

Trademarks = 1

Forward Citations = 89

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Martin Stogniew (14 out of 49 patents)

Javad M Zadei (6 out of 7 patents)

David S Alberts (2 out of 14 patents)

4. David Cassatt (2 out of 3 patents)

5. Christine A Fazenbaker (2 out of 3 patents)

6. Jean Bourhis (2 out of 4 patents)

7. Edward H Kaplan (2 out of 3 patents)

8. Philip S Schein (2 out of 14 patents)

9. Johann Mörsdorf (1 out of 1 patent)

10. Ingomar Grafe (1 out of 7 patents)

11. Alan F List (22 patents)

12. Paul Edwin Kennedy (13 patents)

13. Kurt-Henning Ahrens (2 patents)

14. Robert L Capizzi (2 patents)

15. Johann P Morsdorf (0 patent)

16 patents: Sort by Forward Citations

1. 7368440 - Methods for the administration of amifostine and related compounds (2008-05-06),

2. 7105575 - Methods for the treatment of neuro- disorders using aminothiol compounds (2006-09-12),

3. 7053072 - Methods for the administration of amifostine and related compounds (2006-05-30),

4. 6841545 - Stable amorphous amifostine compositions and methods for the preparation of same (2005-01-11),

5. 6753323 - Topical administration of amifostine and related compounds (2004-06-22),

6. 6586476 - Methods for the treatment of nephro-disorders using aminothiol compounds (2003-07-01),

7. 6576635 - Compositions comprising trimetrexate (2003-06-10),

8. 6573253 - Methods for the administration of amifostine and related compounds (2003-06-03),

9. 6489312 - Pharmaceutical formulations comprising aminoalkyl phosphorothioates (2002-12-03),

10. 6407278 - Stable amorphous amifostine compositions and methods for the preparation and use of the same (2002-06-18),

11. 6384259 - Stable amorphous amifostine compositions and dosage form (2002-05-07),

12. 6258952 - Thermally stable trimetrexates and processes for producing the same (2001-07-10),

13. 6258821 - Compositions comprising trimetrexate and methods of their synthesis and use (2001-07-10),

14. 6239119 - Topical administration of amifostine and related compounds (2001-05-29),

15. 6218377 - Methods for the administration of amifostine and related compounds (2001-04-17),

Medimmune Oncology, Inc. is a leading biopharmaceutical company focused on developing innovative cancer treatments. With a strong pipeline of promising therapies, the company is dedicated to improving the lives of cancer patients through cutting-edge research and development. Visit our website to learn more about our groundbreaking work in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#27 in Gaithersburg, MD

#265 in Maryland

#19,271 in US

#36,634 in the World

Gaithersburg, MD, United States of America

Medimmune Oncology, Inc.

Forward Citations = 89

16 inventors:

Martin Stogniew (14 out of 49 patents)

Javad M Zadei (6 out of 7 patents)

David S Alberts (2 out of 14 patents)

4. David Cassatt (2 out of 3 patents)

5. Christine A Fazenbaker (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…